Tradestie Institutional Equity Comparison Engine

IRWD vs VNDA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IRWD Overall Edge

IRWD Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ironwood Pharmaceuticals, Inc. - Class A (IRWD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IRWD trades at 12.3x Forward P/E with 62.9% operating margin (+9.0% YoY revenue) versus VNDA at 103.1x Forward P/E and -77.6% operating margin (+24.1% YoY). In options structure, IRWD sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IRWD
IRWD 12.3x vs VNDA 103.1x Fwd P/E
Growth & Margin Winner IRWD
Op Margin 62.9% vs -77.6% ยท YoY +9.0% vs +24.1%
Momentum & Technical Winner IRWD
1Y +43.8% vs -12.6% ยท 52W Pos 67% vs 4%
Options & Structure Winner IRWD
CONSOLIDATION (6th %ile IV) vs BREAKDOWN (75th %ile IV)
IRWD NASDAQ
Ironwood Pharmaceuticals, Inc. - Class A
Pharmaceutical Preparations
$4.84
+0.31% 1D
Market Cap $802.9M
1M Return +38.43%
1Y Return +43.77%
Forward P/E 12.3x
Unified AI Score
34.8 / 100 SELL
Tech 50.0 Fund 33.0 Flow 66.0 Mom 40.0
VNDA NASDAQ
Vanda Pharmaceuticals Inc.
Pharmaceutical Preparations
$3.79
-4.89% 1D
Market Cap $238.9M
1M Return -5.83%
1Y Return -12.56%
Forward P/E 103.1x
Unified AI Score
49.0 / 100 HOLD
Tech 56.0 Fund 58.0 Flow 65.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IRWD +43.77% VNDA -12.56% Spread: +56.33 pp (IRWD Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period IRWD Revenue VNDA Revenue IRWD Op. Margin VNDA Op. Margin Margin Edge
FY2018 $350M $190M -43.5% 11.3% VNDA
FY2019 $430M $230M 28.0% 10.0% IRWD
FY2020 $390M $250M 36.7% 11.0% IRWD
FY2021 $410M $270M 56.1% 15.7% IRWD
FY2022 $410M $250M 61.0% 2.5% IRWD
FY2023 $440M $190M -213.5% -7.2% VNDA
FY2024 $350M $200M 26.5% -20.5% IRWD
FY2025 $300M $220M 33.3% -70.0% IRWD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IRWD (7) vs VNDA (3)
Institutional Metric IRWD VNDA Criterion Row Winner
Market Capitalization Scale $802.9M $238.9M Larger Scale IRWD
Trailing P/E Ratio Valuation 5.4x 103.1x Lower Multiple IRWD
Forward P/E Ratio Valuation 12.3x 103.1x Lower Multiple IRWD
Revenue Growth (YoY) Growth +9.0% +24.1% Higher Growth VNDA
Operating Margin (TTM) Profitability 62.9% -77.6% Higher Margin IRWD
Net Profit Margin Profitability 37.4% -119.9% Higher Margin IRWD
Return on Equity (ROE) Capital Efficiency -574.7% -82.5% Higher ROE VNDA
52-Week Range Position Momentum 67% ($3โ€“$6) 4% ($4โ€“$10) Stronger Trend IRWD
Beta / 30D Volatility Risk Regime 1.38ฮฒ ยท 54% Vol 1.25ฮฒ ยท 61% Vol Lower Realized Risk IRWD
Unified Institutional Score Composite Signal 34.8 / 100 (SELL) 49.0 / 100 (HOLD) Higher Composite VNDA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IRWD vs VNDA Buy Guide
IRWD CONSOLIDATION
134d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live IRWD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VNDA BREAKDOWN
174d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 75th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live VNDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IRWD nor VNDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.